167172-92-1 Usage
Uses
Used in Pharmaceutical Research:
(R)-6-BROMO-2-AMINOTETRALIN is used as a research compound for its potential biological activities. Its unique structure allows it to be a promising candidate in the development of new medications, particularly for various diseases and medical conditions. (R)-6-BROMO-2-AMINOTETRALIN's properties make it an interesting target for investigation in the field of medicinal chemistry.
Used in Medicinal Chemistry:
(R)-6-BROMO-2-AMINOTETRALIN serves as a valuable compound in the field of medicinal chemistry, where its structure and properties are explored for potential applications in treating different diseases and medical conditions. (R)-6-BROMO-2-AMINOTETRALIN's potential uses are still under investigation, and further research is required to determine its full range of applications and activities.
Check Digit Verification of cas no
The CAS Registry Mumber 167172-92-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,7,1,7 and 2 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 167172-92:
(8*1)+(7*6)+(6*7)+(5*1)+(4*7)+(3*2)+(2*9)+(1*2)=151
151 % 10 = 1
So 167172-92-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H12BrN/c11-9-3-1-8-6-10(12)4-2-7(8)5-9/h1,3,5,10H,2,4,6,12H2/t10-/m1/s1
167172-92-1Relevant academic research and scientific papers
Asymmetric Synthesis of MK-0499
Tschaen, David M.,Abramson, Lee,Cai, Dongwei,Desmond, Richard,Dolling, Ulf-H.,et al.
, p. 4324 - 4330 (2007/10/02)
Described herein is an efficient asymmetric synthesis of the potent antiarrhthymia agent MK-0499.The route is convergent and is highlighted by two stereoselective reactions.A ruthenium-catalyzed, enantioselective hydrogenation of an enamide was developed for the preparation of the key amine intermediate.Oxazaborolidine-mediated ketone reduction was utilized to establish the alcohol stereochemistry.Optimization of this chemistry led to an IPA modified reduction method which provides enhanced stereoselectivity.
